Abstract
TREATMENT AND CLINICAL OUTCOME OF PATIENTS WITH CORONAVIRUS DISEASE

*Razia Ansari, R.Shivani and Dr. Nikhil Kumar Vanajari

ABSTRACT

The COVID-19 outbreak has brought our lives to a sudden and complete lockdown. While the numbers of confirmed cases and deaths still rise, people round the world are taking brave actions to mitigate transmission and save lives. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a characteristic hyper inflammatory response, vascular damage, micro-angiopathy, angiogenesis and widespread thrombosis. During this emergency period of the COVID-19 outbreak, clinical researchers are using and testing a spread of possible treatments. Combination treatment of low-dose systematic corticosteroids and anti-virals, anti- coagulants, use of statins, zinc , role of vitamin C, D and convalescent plasma have been encouraged as part of critical COVID-19 management. Vaccine-associated enhanced disease has been rarely encountered with existing vaccines or viral infection. Safe and effective vaccines are a game-changing tool: but for the foreseeable future we must continue wearing masks, cleaning our hands, ensuring good ventilation indoors, physically distancing and avoiding crowds. But it’s not vaccines that will stop the pandemic, it’s vaccination. We must all do our part to keep each other safe until this outbreak subsides and humanity are back to being greater than ever.

Keywords: COVID-19, Outbreak, Treatment, Clinical Research, Vaccine.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2022 Issue has been successfully launched on 1 October 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT